CannabCo set to capture market with high THC Odourless Cannabis™ Products
BRAMPTON, ON – CannabCo Pharmaceutical Corp. (CannabCo), a Canadian company located in Brampton, Ontario, is pleased to announce a milestone achievement with the testing of one of the industry’s most potent cannabis strains at 41% total quantifiable cannabinoid content. The strain features a lab tested cannabinoid count of 40.59% with a THC rating of 35%. The main distinguishing feature of the strain, other than its high THC content, is that it was created with Purecann™, CannabCo’s proprietary Odourless Cannabis™ technology.
The deployment of Purecann™ makes the product virtually odourless when smoked or stored allowing for a reduced impact on others sensitive to the pungent odour of cannabis. This is an industry first and a product the company claims is sorely needed in the marketplace.
The company has developed and tested multiple Purecann™ strains ranging from under .3% for the smoke-able hemp market, with numerous strains in the 20-32% range, culminating to the highest THC range currently at 35%.
Currently the highest THC dry flower in the Ontario Cannabis Store lists at a maximum of 32% THC. Mark Pellicane, CannabCo’s CEO, thinks they can do better. “We are always pushing the limits with our technologies” said Pellicane, “With the demand for high THC strains, it made sense to target the same in odourless variants and our result is one of the highest THC strains produced to date”. Pellicane also stated that the company has multiple strains in the high 30’s in the works, as well as market specific strains with targeted THC levels and cannabinoid profiles for specific markets and effects.
“We’ve taken the time during the COVID-19 pandemic to developed products suitable for multiple target markets” said Mark Novak, the company’s COO. “For example, Israel currently has a THC cap on dry bud, so we’ve developed products specific to the 20-25% range in order to maximize consumer uptake for that specific medical and pending recreational markets”. The company has been approached for Purecann™ deployment in multiple markets such as the USA, EU, Israel, Australia, and South America.
The company intends to continue to develop innovative and first to market products, with its undisclosed technology and grow partner. CannabCo maintains full ownership and rights to Purecann™ and the odourless cannabis™ technology.
About CannabCo Pharmaceutical Corp.
CannabCo Pharmaceutical Corp. is a Canadian based full service cannabis company with operations in Brampton, Ontario. The company has received its “Confirmation of Readiness” from Health Canada to become a licensed producer and is currently building out its pilot facility in the Brampton Area. The company currently has two primary technologies, Purecann™ for the growing of Odourless Cannabis™, and PHOENIX, and enhanced cultivation system featuring a hydroponic grow system with high productivity and significantly lower cost per gram than traditional grows.
Forward Looking Statements
This press release may contain certain “forward-looking information” and “forward-looking statements” within the meaning of applicable securities legislation. All information contained herein that is not historical in nature may constitute forward-looking information. Forward-looking statements may be identified by statements containing the words “believes”, “anticipates”, “plans”, “intends”, “will”, “should”, “expects”, “continue”, “estimate”, “forecasts” and other similar expressions. Actual results and developments may differ materially from those contemplated by these statements. Although CannabCo believes that the expectations reflected in forward-looking statements in this press release are reasonable, there can be no assurance that such statements will prove to be accurate. Future events and results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements in this press release. Comments and claims related to PHOENIX and PURECANN are based solely on that observed and the opinions of management as well as third party verifications provided to CannabCo from industry experts.
- Mississippi House amends medical cannabis bill, returns to SenateThe House on Wednesday passed a Senate medical marijuana proposal, but only after changing the bill to lower the amount of cannabis a patient could get. The vote was 104-14 on the amended Senate Bill 2095.
- Cheech & Chef: Comedy legend fronts “stoner food” delivery service“With the pandemic, you want to go out,” Cheech Marin tells Profiles in Legalization, “but it’s tough to get into some places. So if you can order from them and have them deliver… Yay! Progress.”
- Florida’s growing medical cannabis program could lead to changesWith Florida’s medical marijuana program continuing to grow as more patients seek approval for marijuana cards, some state lawmakers in the 2022 session are pursuing changes to make it easier to access medical marijuana, raising concerns from some marijuana activists that physicians could be negatively impacted.
- Senate overwhelmingly passes Mississippi medical cannabisThe vote on Senate Bill 2095 was initially counted as 45-5, well beyond what would be considered a veto-proof majority, but subject to change as it was by use of morning roll call and senators could change their votes or check in through the end of the day.
- Ohio cannabis legalization group turns in additional signaturesThe Coalition to Regulate Marijuana Like Alcohol submitted 29,918 additional signatures in support of an initiated statute legalizing the adult use of marijuana to the Ohio Secretary of State’s office today.
- Senate vote on Mississippi medical cannabis bill expected Thursday. Here’s a look at the bill.After years of debate and hang-fire, a Mississippi medical marijuana program for people with chronic and debilitating illnesses inched forward Wednesday, with a Senate committee passing a bill along to the full chamber.
- Virginia lawmakers still at odds over resentencing for people in prison on cannabis chargesNearly a year after Virginia lawmakers voted to legalize possession of marijuana, they remain divided on what — if anything — to do about people currently imprisoned on marijuana charges.
- Opinion: We need Social Equity in all cannabis industries now“It’s time that we establish more robust social equity programs that allow all to thrive in this industry. It shouldn’t just be those who have institutional money or come from a position of privilege.”
- As clock ticks, headwinds build against Mississippi medical cannabisFor some time after the Supreme Court shot down a vote of the people to create a Mississippi medical marijuana, it appeared fait accompli that lawmakers would enact a program, per the “will of the voters.” That outcome is now in doubt.
- Oregon enforces new federal hemp rules for state growersHemp growers in the state will now need to abide by several new federal regulations that will be overseen by the Oregon Department of Agriculture. The changes come at a time of growing concerns over illegal marijuana operations in parts of southern Oregon.